Unveiling Public Finance Trends: AI Insights & Gapsby Terry Bingman 16.02.2024A new study in public finance and budgeting reveals leading topics and future research agendas, emphasizing the need for practitioner ...
Amazon Prime Faces Backlash Over Introduction of Commercialsby Lilu Anderson 16.02.2024Amazon Prime Video's decision to introduce commercials has sparked outrage among subscribers, leading to a class-action lawsuit. The move also ...
Ethereum’s Critical Upgrade Call: What’s Next?by John Darbie 16.02.2024The Ethereum community discusses Dencun and Pectra upgrades in their recent call. Key topics include preparations for the Dencun upgrade ...
Uniswap V4 Launch: Revolutionizing DeFi Worldby John Darbie 16.02.2024The Uniswap Foundation announces the launch of 'Uniswap v4' following Ethereum's Dencun upgrade. Uniswap's native token, UNI, shows a bullish ...
Attorneys React: Venture Capital Exits Hit Decade Lowby Mark Eisenberg 16.02.2024Attorneys witnessed lowest venture capital exits since pandemic and 2008 market crash, as per Bain & Co. report. M&A market ...
Paramount and Comcast in Talks for Streaming Partnershipby Mark Eisenberg 16.02.2024Paramount Global is in talks with Comcast for a potential streaming partnership or joint venture. Combining their services could lead ...
Solana Emerges as Crypto Powerhouse: 380% Surge!by John Darbie 16.02.2024Solana has become the fifth-largest crypto with a 380% growth in 12 months, driven by developments and high returns. Their ...
Datasea’s Bold Move: $30M Boost in China’s 5G Marketby Lilu Anderson 16.02.2024Datasea Inc. collaborates with Hangzhou Chongda Technology to boost sales of its 5G multimodal communication services in China, aiming to ...
Iridium Adjusts Amid Starlink Rivalry: Hold or Buy?by Mark Eisenberg 16.02.2024Iridium Communications' rating has shifted from Buy to Hold, due to accounting changes and increased competition. Potential value through inventory ...
Cellebrite Stock Upgraded by BofA: Buy Now!by Mark Eisenberg 16.02.2024Bank of America Securities upgrades Cellebrite stock to Buy, increasing price target to $12. Improved business momentum and strong market ...